{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:06:27Z","timestamp":1773723987191,"version":"3.50.1"},"reference-count":109,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches. Cardiac magnetic resonance imaging (MRI) emerges as a promising tool, offering insights into hemodynamic parameters and providing valuable prognostic information. The potential of biomarkers, alongside pulmonary function and cardiopulmonary exercise tests, is explored for enhanced diagnostic and prognostic precision. While specific treatments for PH-ILD remain limited, recent studies on inhaled treprostinil provide new hope for improved patient outcomes.<\/jats:p>","DOI":"10.3390\/medicina60010058","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T09:56:27Z","timestamp":1703757387000},"page":"58","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8005-8672","authenticated-orcid":false,"given":"Vaida","family":"Averjanovait\u0117","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6957-2985","authenticated-orcid":false,"given":"Lina","family":"Gumbien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrida","family":"Zeleckien\u0117","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-5611","authenticated-orcid":false,"given":"Virginija","family":"\u0160ileikien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/resp.12986","article-title":"Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction","volume":"22","author":"Teramachi","year":"2017","journal-title":"Respirology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2101483","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: Results from the COMPERA registry","volume":"58","author":"Olsson","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.00107206","article-title":"Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant","volume":"30","author":"Shorr","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.rmed.2012.02.015","article-title":"Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test","volume":"106","author":"Andersen","year":"2012","journal-title":"Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pulito-Cueto, V., Genre, F., L\u00f3pez-Mej\u00edas, R., Mora-Cuesta, V.M., Iturbe-Fern\u00e1ndez, D., Portilla, V., Sebasti\u00e1n Mora-Gil, M., Ocejo-Vinyals, J.G., Gualillo, O., and Blanco, R. (2023). Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021275"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1164\/rccm.202109-2174OC","article-title":"Vascular\u2013Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling","volume":"207","author":"Yanagihara","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Samarelli, A.V., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., Manicardi, L., Moretti, A., and Tabb\u00ec, L. (2021). Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168952"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mi\u0105dlikowska, E., Rzepka-Wrona, P., Mi\u0142kowska-Dymanowska, J., Bia\u0142as, A.J., and Piotrowski, W.J. (2021). Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features\u2014What Do We Already Know?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010079"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e170502","DOI":"10.1172\/JCI170502","article-title":"The vascular perspective on acute and chronic lung disease","volume":"133","author":"Borek","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1113\/EP087321","article-title":"Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension","volume":"104","author":"Darwiche","year":"2019","journal-title":"Exp. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e000532","DOI":"10.1136\/bmjresp-2019-000532","article-title":"Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation","volume":"7","author":"Dotan","year":"2020","journal-title":"BMJ Open Respir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2006.06.007","article-title":"Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics","volume":"38","author":"Colombat","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apha.12749","article-title":"The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension","volume":"219","author":"Kylhammar","year":"2017","journal-title":"Acta Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5588\/ijtld.12.0428","article-title":"Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function","volume":"17","author":"Maimon","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/CPM.0000000000000252","article-title":"Sarcoidosis-associated Pulmonary Hypertension: Pathophysiology, Diagnosis, and Treatment","volume":"25","author":"Duong","year":"2018","journal-title":"Clin. Pulm. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1430350","DOI":"10.1155\/2017\/1430350","article-title":"Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives","volume":"2017","author":"Collum","year":"2017","journal-title":"Can. Respir. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccl.2016.04.003","article-title":"Group III Pulmonary Hypertension","volume":"34","author":"Klinger","year":"2016","journal-title":"Cardiol. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pupt.2018.03.002","article-title":"Pulmonary hypertension in patients with interstitial lung disease","volume":"50","author":"Karampitsakos","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2008.091710","article-title":"Systemic sclerosis and its pulmonary complications in The Netherlands: An epidemiological study","volume":"68","author":"Vonk","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","article-title":"Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: Screening allows for earlier diagnosis","volume":"39","author":"Phung","year":"2009","journal-title":"Intern. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-017-1250-z","article-title":"Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: Results from a real-life screening programme","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41512","article-title":"Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease","volume":"73","author":"Chauvelot","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12213","DOI":"10.1002\/pul2.12213","article-title":"Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute\u2019s Innovative Drug Development Initiative\u2014Group 3 Pulmonary Hypertension","volume":"13","author":"Piccari","year":"2023","journal-title":"Pulm. Circ."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/COPD.S286360","article-title":"Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management","volume":"16","author":"Hage","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.12-2403","article-title":"Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis","volume":"144","author":"Ryerson","year":"2013","journal-title":"Chest"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000099","DOI":"10.1136\/bmjresp-2015-000099","article-title":"Combined pulmonary fibrosis and emphysema: Effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease","volume":"3","author":"Tomioka","year":"2016","journal-title":"BMJ Open Respir. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/rcr2.7","article-title":"Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension","volume":"1","author":"Sato","year":"2013","journal-title":"Respirol. Case Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pulmoe.2020.01.004","article-title":"Connective tissue disease-associated interstitial lung disease","volume":"28","author":"Oliveira","year":"2022","journal-title":"Pulmonology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20458940211011329","article-title":"Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: A prospective cohort study","volume":"11","author":"Saggar","year":"2021","journal-title":"Pulm. Circ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/09031936.00093111","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: Characteristics in 20 patients","volume":"40","author":"Cottin","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13023-017-0626-0","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: Prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method","volume":"12","author":"Freitas","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11684-018-0634-z","article-title":"Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: An observation on 50 patients","volume":"13","author":"Wu","year":"2019","journal-title":"Front. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0970-2113.177433","article-title":"Tuberculosis associated pulmonary hypertension: The revelation of a clinical observation","volume":"33","author":"Bhattacharyya","year":"2016","journal-title":"Lung India"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3904\/kjim.2014.122","article-title":"Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: Results from the Korean registry","volume":"31","author":"Park","year":"2016","journal-title":"Korean J. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/S2214-109X(22)00042-0","article-title":"Post-tuberculosis pulmonary hypertension: A case of global disparity in health care","volume":"10","author":"Walsh","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_42","first-page":"1","article-title":"Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: A patient experience study of symptoms and their impact on quality of life","volume":"11","author":"DuBrock","year":"2021","journal-title":"Pulm. Circ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12127","DOI":"10.1002\/pul2.12127","article-title":"Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute\u2019s innovative drug development initiative\u2014Group 3 pulmonary hypertension","volume":"12","author":"Nikkho","year":"2022","journal-title":"Pulm. Circ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.jacc.2006.07.061","article-title":"Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers","volume":"48","author":"Hoeper","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gl\u00e4ser, S., Obst, A., Koch, B., Henkel, B., Grieger, A., Felix, S.B., Halank, M., Bruch, L., Bollmann, T., and Warnke, C. (2013). Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis\u2014The Predictive Value of Exercise Capacity and Gas Exchange Efficiency. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065643"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"210220","DOI":"10.1183\/16000617.0220-2021","article-title":"Recent advances in the management of pulmonary hypertension with interstitial lung disease","volume":"31","author":"Waxman","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1701311","DOI":"10.1183\/13993003.01311-2017","article-title":"A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis","volume":"51","author":"Furukawa","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.rmed.2007.05.012","article-title":"Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"101","author":"Zisman","year":"2007","journal-title":"Respir. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/art.39528","article-title":"Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension","volume":"68","author":"Antoniou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"200355","DOI":"10.1183\/16000617.0355-2020","article-title":"Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency","volume":"30","author":"Gille","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1843.2010.01909.x","article-title":"Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension: Pulmonary hypertension in lung fibrosis","volume":"16","author":"Boutou","year":"2011","journal-title":"Respirology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/resp.12206","article-title":"Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis: Pulmonary vascular impairment in IPF","volume":"19","author":"Blumenthal","year":"2014","journal-title":"Respirology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ewert, R., Ittermann, T., Habedank, D., Held, M., Lange, T.J., Halank, M., Winkler, J., Gl\u00e4ser, S., Olschewski, H., and Kovacs, G. (2019). Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis. BMC Pulm. Med., 19.","DOI":"10.1186\/s12890-019-1003-7"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x","article-title":"Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis: HRR and PH in IPF","volume":"16","author":"Swigris","year":"2011","journal-title":"Respirology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Alhamad, E.H., Cal, J.G., Alrajhi, N.N., and Alharbi, W.M. (2020). Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123828"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000491095","article-title":"Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias","volume":"96","author":"Yoo","year":"2018","journal-title":"Respiration"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.21037\/cdt.2018.01.10","article-title":"Imaging of pulmonary hypertension: An update","volume":"8","author":"Goerne","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"20200830","DOI":"10.1259\/bjr.20200830","article-title":"Computed tomography appearances of the lung parenchyma in pulmonary hypertension","volume":"94","author":"Foley","year":"2021","journal-title":"Br. J. Radiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"966257","DOI":"10.3389\/fcvm.2022.966257","article-title":"Efficacy of computed tomography in diagnosing pulmonary hypertension: A systematic review and meta-analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1378\/chest.113.5.1250","article-title":"Utility of CT Scan Evaluation for Predicting Pulmonary Hypertension in Patients With Parenchymal Lung Disease","volume":"113","author":"Tan","year":"1998","journal-title":"Chest"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1007\/s00330-020-06846-1","article-title":"Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension","volume":"30","author":"Swift","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1097\/MD.0000000000000256","article-title":"CT-Base Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension: A Meta-Analysis and Systematic Review","volume":"93","author":"Shen","year":"2014","journal-title":"Medicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1378\/chest.07-0116","article-title":"High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis","volume":"132","author":"Zisman","year":"2007","journal-title":"Chest"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clinimag.2014.02.004","article-title":"Pulmonary arterial enlargement in patients with acute exacerbation of interstitial pneumonia","volume":"38","author":"Matsushita","year":"2014","journal-title":"Clin. Imaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.21037\/cdt-20-295","article-title":"The role of imaging in pulmonary hypertension","volume":"11","author":"Sharma","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2214\/AJR.17.19208","article-title":"Egg-and-Banana Sign: A Novel Diagnostic CT Marker for Pulmonary Hypertension","volume":"210","author":"Scelsi","year":"2018","journal-title":"Am. J. Roentgenol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1053\/j.sult.2012.06.002","article-title":"The Imaging of Pulmonary Hypertension","volume":"33","author":"Frazier","year":"2012","journal-title":"Semin. Ultrasound CT MRI"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894019890549","article-title":"Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)","volume":"9","author":"Kiely","year":"2019","journal-title":"Pulm. Circ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"G11","DOI":"10.1530\/ERP-17-0071","article-title":"Echocardiographic assessment of pulmonary hypertension: A guideline protocol from the British Society of Echocardiography","volume":"5","author":"Augustine","year":"2018","journal-title":"Echo Res. Pract."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/crj.12608","article-title":"Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation","volume":"12","author":"Nowak","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/joim.13179","article-title":"Right cardiac involvement in lung diseases: A multimodality approach from diagnosis to prognostication","volume":"289","author":"Mandoli","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/anae.12861","article-title":"The utility of transoesophageal echocardiography for estimating right ventricular systolic pressure","volume":"70","author":"Cowie","year":"2015","journal-title":"Anaesthesia"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e033084","DOI":"10.1136\/bmjopen-2019-033084","article-title":"Diagnostic accuracy of transthoracic echocardiography for pulmonary hypertension: A systematic review and meta-analysis","volume":"9","author":"Ni","year":"2019","journal-title":"BMJ Open"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1183\/09031936.02.00014602","article-title":"Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure","volume":"20","author":"Saba","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2431060067","article-title":"Pulmonary Hypertension: Accuracy of Detection with Left Ventricular Septal-to\u2013Free Wall Curvature Ratio Measured at Cardiac MR","volume":"243","author":"Dellegrottaglie","year":"2007","journal-title":"Radiology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1148\/radiol.12111599","article-title":"Regional and Global Biventricular Function in Pulmonary Arterial Hypertension: A Cardiac MR Imaging Study","volume":"266","author":"Shehata","year":"2013","journal-title":"Radiology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcmg.2015.12.015","article-title":"MR and CT Imaging for the Evaluation of Pulmonary Hypertension","volume":"9","author":"Freed","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_79","first-page":"OA3523","article-title":"Prognostic value of MRI in pulmonary arterial hypertension: Early and late predictors. 43 Pulmonary Circulation and Pulmonary Vascular Disease","volume":"46","author":"Swift","year":"2015","journal-title":"Eur. Respir. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.201611-2365OC","article-title":"Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension","volume":"196","author":"Swift","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/rccm.201909-1771OC","article-title":"Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension","volume":"201","author":"Lewis","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcmg.2013.01.013","article-title":"Noninvasive Estimation of PA Pressure, Flow, and Resistance With CMR Imaging","volume":"6","author":"Swift","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jbiomech.2014.07.024","article-title":"MRI model-based non-invasive differential diagnosis in pulmonary hypertension","volume":"47","author":"Lungu","year":"2014","journal-title":"J. Biomech."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.2019192078","article-title":"MRI Prediction of Precapillary Pulmonary Hypertension according to the Sixth World Symposium on Pulmonary Hypertension","volume":"294","author":"Whitfield","year":"2020","journal-title":"Radiology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1016994","DOI":"10.3389\/fcvm.2023.1016994","article-title":"Non-invasive detection of severe PH in lung disease using magnetic resonance imaging","volume":"10","author":"Alkhanfar","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.121.319990","article-title":"Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart","volume":"130","author":"Alenezi","year":"2022","journal-title":"Circ. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"924873","DOI":"10.3389\/fcvm.2022.924873","article-title":"An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers","volume":"9","author":"Gandra","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.rmed.2012.09.003","article-title":"Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease","volume":"106","author":"Andersen","year":"2012","journal-title":"Respir. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1164\/rccm.201309-1592OC","article-title":"C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis","volume":"189","author":"Vuga","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/resp.13302","article-title":"S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension: S100A12 in pulmonary hypertension","volume":"23","author":"Tzouvelekis","year":"2018","journal-title":"Respirology"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Parikh, R., Konstantinidis, I., O\u2019Sullivan, D.M., and Farber, H.W. (2022). Pulmonary hypertension in patients with interstitial lung disease: A tool for early detection. Pulm. Circ., 12.","DOI":"10.1002\/pul2.12141"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.rmed.2014.12.011","article-title":"Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model","volume":"109","author":"Ruocco","year":"2015","journal-title":"Respir. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2022.12.016","article-title":"A machine learning approach to identifying patients with pulmonary hypertension using real-world electronic health records","volume":"374","author":"Kogan","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.healun.2020.04.009","article-title":"Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography","volume":"39","author":"Kwon","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"19311","DOI":"10.1038\/s41598-020-76359-w","article-title":"Deep learning to predict elevated pulmonary artery pressure in patients with suspected pulmonary hypertension using standard chest X ray","volume":"10","author":"Kusunose","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2045894020961713","DOI":"10.1177\/2045894020961713","article-title":"Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases","volume":"10","author":"Sprecher","year":"2020","journal-title":"Pulm. Circ."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"220271","DOI":"10.1183\/20734735.0271-2022","article-title":"Oxygen in interstitial lung diseases","volume":"19","author":"Cordeiro","year":"2023","journal-title":"Breathe"},{"key":"ref_98","first-page":"CD006322","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"210017","DOI":"10.1183\/16000617.0017-2021","article-title":"Lung transplantation for interstitial lung disease","volume":"30","author":"Kapnadak","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"992879","DOI":"10.3389\/fcvm.2022.992879","article-title":"PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis","volume":"9","author":"Zhao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","article-title":"The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease","volume":"158","author":"King","year":"2020","journal-title":"Chest"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman, D.A., Schwarz, M., Anstrom, K.J., Collard, H.R., Flaherty, K.R., and Hunninghake, G.W. (2010). A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N. Engl. J. Med., 363, 620\u2013628.","DOI":"10.1056\/NEJMoa1002110"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_104","first-page":"OA1985","article-title":"RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia","volume":"50","author":"Nathan","year":"2017","journal-title":"Eur. Respir. Soc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000345221","article-title":"Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis","volume":"85","author":"Kimura","year":"2013","journal-title":"Respiration"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.athoracsur.2015.06.024","article-title":"Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Suzuki, A., Taniguchi, H., Watanabe, N., Kondoh, Y., Kimura, T., Kataoka, K., Matsuda, T., Yokoyama, T., Sakamoto, K., and Nishiyama, O. (2014). Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108339"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/58\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:43:20Z","timestamp":1760132600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["medicina60010058"],"URL":"https:\/\/doi.org\/10.3390\/medicina60010058","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}